| |
|
 |
Prostate cancer’s Achilles heel
Dr. Mike Cox is looking at how to stop prostate cancer cells from turning cholesterol into testosterone in advanced cancers. Prostate cancer uses testosterone to grow, so stopping its supply could be a way to kill them.
|
 |
Using the body’s own cells to kill cancer
Dr. Ryan Wylie is researching whether immune cells could be used to kill cancer. If he can find a way, then drugs could make prostate cancer a chronic disease treated through medication, like high cholesterol.
|
 |
More than testosterone
Dr. Éric Lévesque is using the latest technological advances to look into the role of male hormones in prostate cancer. The role of testosterone is well studied – but there are many others he is looking at to determine if they have a role as well.
|
 |
Too old to be treated for prostate cancer?
Dr. Shabbir Alibhai is working with older, frailer men to see if daily tracking of their symptoms during treatment can lead to earlier intervention, and ideally help them live better and longer.
|
 |
Surviving Cancer – now what?
Dr. Jennifer Jones has been researching prostate cancer survivorship since 1994. Read her story and watch her speak about her current research. Dr. Jennifer Jones discusses her recent research into prostate cancer survivorship.
|
 |
Study could help doctors decide which patients need treatment
A big challenge in prostate cancer is figuring out which men need treatment right away. Drs. Paul Boutros and Thomas Kislinger are close to identifying whether men have aggressive prostate cancer that needs immediate action. |
 |
Hidden clue in blood could help fight against aggressive prostate cancer
Dr. Hansen He is working to develop a blood test to distinguish slow-growing and aggressive prostate cancer. |
 |
Seeking answers to an aggressive form of advanced prostate cancer
Drs. Paul Boutros and Hansen He are looking for better treatments for a deadly type of prostate cancer – neuroendocrine prostate cancer. |
 |
Close to a breakthrough on an aggressive form of advanced prostate cancer
Dr. Amina Zoubeidi and her team are coming close to developing a drug to treat neuroendocrine prostate cancer – a deadly form of prostate cancer for which there is no effective treatment. |
 |
Reflecting on 25 years of impact
Dr. Laurence Klotz was part of the team that received Prostate Cancer Canada’s first research grant, which contributed to the development of active surveillance – an approach now used around the world. |
 |
Can you inherit prostate cancer?
Dr. Danny Verspirini and his team are studying the BRCA2 gene and its connection to prostate cancer. |
 |
Uncovering prostate cancer mysteries in unexpected places
Dr. Bapat Bharati and her team are looking at urine to see if there are markers in it for predict low-risk prostate cancer and cancer that is likely to spread. |
 |
Low oxygen in tumour cells leads to important discovery
Dr. Paul Boutros and his team have discovered markers in tumour cells with low oxygen that could predict cancer progression. |
 |
From idea to possibility: Moving research from the lab to patient care
Dr. Paul Rennie and his team are developing new ways to treat aggressive prostate cancer by targeting the cancer’s hormone receptors. |